Which infusion pump do patients prefer? new study aims to find out

NCT ID NCT07189013

Not yet recruiting Symptom relief Sponsor: KORU Medical Systems, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how patients with primary or secondary immunodeficiency feel about using mechanical versus electronic infusion pumps for their immunoglobulin therapy. About 52 adults who have used electronic pumps will try a mechanical pump for three months and then report their satisfaction. The goal is to see if the mechanical pump is preferred, which could help guide future choices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mechanical infusion pump (Freedom60)
What this could lead to: If successful, this could help patients and doctors choose infusion pumps that are easier and more comfortable to use.
What could go wrong: This is a small, early-stage preference study, not a treatment trial. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates